期刊
INTERNATIONAL IMMUNOPHARMACOLOGY
卷 14, 期 4, 页码 446-453出版社
ELSEVIER
DOI: 10.1016/j.intimp.2012.08.020
关键词
Lactobacillus reuteri CRL1098; Lipid rafts; PBMC; TNF-alpha; Secreted peptide
资金
- CONICET
- Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina
- CIUNT-UNT
The aim of the present study was to evaluate the capacity of Lactobacillus reuteri CRL1098 soluble factors (Lr-S) to modulate TNF-alpha production in peripheral blood mononuclear cells (PBMC) and to study lipid rafts participation in this response. PBMC treated with Lr-S showed a reduced production of TNF-alpha. In addition, Lr-S treatment activated ERK and p38 MAPK pathways in PBMC. Lipid rafts participation in the reduced production of TNF-alpha by PBMC induced by Lr-S was verified by lipid rafts disruption with methyl-beta-cyclodextrin and the reduction of the Src-tyrosine kinase Lck localization in rafts. Moreover, PBMC pre-treatment with Lck inhibitors blocked the effect of Lr-S on TNF-alpha production suggesting that activation and mobilization of Lck from lipid rafts would be involved in the modulatory effect of L reuteri CRL1098. A secreted peptide of 5785 Da would be responsible of the modulatory effect of CRL1098 strain. This study demonstrated for the first time the lipid rafts participation in a response induced by a beneficial bacterium. Also, these results open new possibilities for investigating the molecular mechanisms involved in the interaction of probiotic bacterial extracellular compounds with immune cells. (C) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据